EUVIMEDEUVIMED entdecken
Übersichtsarbeit

From Sulfa Drugs to New Antibacterial Agents: Advances in Chemical Modification of Approved Sulfonamides

Ayşe Karagüzel, Ebru Koçak Aslan iD, Miyase Gözde Gündüz iD

Drug Development Research · 2025

DOI: 10.1002/ddr.70191 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Development Research, 2025. Verfasst von Ayşe Karagüzel und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Sulfonamides. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 84 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sulfonamides, the oldest synthetic antibacterial agents, specifically target the enzyme dihydropteroate synthase (DHPS), which is essential for the folic acid biosynthesis pathway. In contrast, humans do not use this mechanism as they produce no endogenous folic acid and therefore lack the DHPS enzyme. Despite this unique mechanism and selective action against bacteria, their crucial role in fighting bacterial infections has been diminished by the rise of resistance and allergies to sulfa drugs. To overcome these factors that restrict the application of antibacterial sulfonamides, molecular modification of approved sulfa drugs, such as sulfanilamide, sulfathiazole, and sulfadiazine, appears to be a promising strategy for drug design. This review, for the first time, focuses on the molecular modifications directly performed on sulfa drugs to develop new antibacterial agents that address the resistance and safety problems associated with clinical sulfonamides. These modifications involve the conjugation of commercial sulfa drugs with various heterocycles (triazole, thiazole, thiophene, etc.), functional groups (hydrazone, Schiff base, azo dye, urea/thiourea), phytochemicals (thymol, eugenol, etc.), and drug molecules, leading to new antibacterial candidates and insights into their structure–activity relationships. Given the growing global threat of antibiotic resistance, this review may help restore the importance of traditional sulfa drugs in treating bacterial infections through effective chemical modifications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsSulfonamidesHumansAnimalsBacterial InfectionsDrug Resistance, BacterialDrug DesignDihydropteroate Synthase

Stichwörter der Autor:innen

antibioticantimicrobialmolecular hybridizationmolecular modificationstructure‐activity relationshipsynthesis

Substanzen

Anti-Bacterial AgentsSulfonamidesDihydropteroate Synthase

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Başkent University, Ankara, Turkey.

ORCID-Profile: Ebru Koçak Aslan, Miyase Gözde Gündüz

Zitieren

APA

Karagüzel, A., Koçak Aslan, E., & Gündüz, M. G. (2025). From Sulfa Drugs to New Antibacterial Agents: Advances in Chemical Modification of Approved Sulfonamides. Drug Development Research. https://doi.org/10.1002/ddr.70191

Vancouver

Karagüzel A, Koçak Aslan E, Gündüz MG. From Sulfa Drugs to New Antibacterial Agents: Advances in Chemical Modification of Approved Sulfonamides. Drug Development Research. 2025. doi:10.1002/ddr.70191

BibTeX
@article{Karagzel2025,
  author = {Karagüzel, Ayşe and Koçak Aslan, Ebru and Gündüz, Miyase Gözde},
  title = {From Sulfa Drugs to New Antibacterial Agents: Advances in Chemical Modification of Approved Sulfonamides},
  journal = {Drug Development Research},
  year = {2025},
  doi = {10.1002/ddr.70191}
}
Kostenlos starten →